Obamacare : Dr Ben Carson Socialized Medicine is the Keystone to a Socialist State (Oct 10, 2013) – Video


Obamacare : Dr Ben Carson Socialized Medicine is the Keystone to a Socialist State (Oct 10, 2013)
SOURCE: http://www.foxnews.com News Articles: Dr. Ben Carson says IRS targeted him for his anti-Obama comments http://www.foxnews.com/politics/2013/10/03/dr-...

By: SignsofThyComing

Read the original post:

Obamacare : Dr Ben Carson Socialized Medicine is the Keystone to a Socialist State (Oct 10, 2013) - Video

Derek Fitzgerald | Heart Transplant and IRONMAN | Penn Medicine TV Commercial – Video


Derek Fitzgerald | Heart Transplant and IRONMAN | Penn Medicine TV Commercial
Television commercial for Penn Heart and Vascular featuring heart transplant patient Derek Fitzgerald. Derek is an IRONMAN® Lake Placid finisher. *IRONMAN® i...

By: pennmedicine

See the original post here:

Derek Fitzgerald | Heart Transplant and IRONMAN | Penn Medicine TV Commercial - Video

Understanding Chinese Herbal Medicine

Chinese herbal medicine uses natural mineral, plant, and animal substances as medicine. These substances have minimum side effects when taken at the right time for the right condition; taken wrongly, they can be harmful.

For example, the herb astragalus (huangqi) taken alone should be used with caution by those who have high blood pressure or high fevers due to acute infections.

It is essential for anyone who wants to benefit from Chinese herbal medicine to consult a doctor of Chinese medicine for evaluation based on the theories and diagnostic techniques of Chinese medicine, including pulse and tongue reading.

When evaluating a patient, the Chinese medicine practitioner first has to identify which meridians and organ systems are out of balance. For example, liver and stomach meridians are often affected in indigestion. The practitioner has to determine the nature of the energy imbalance, such as too much or too little energy or energy that is stagnated, blocked, or moving in the wrong direction.

Take acid reflux as an example. It may be stagnated liver energy affecting the normal flow of stomach energy, which is now moving in the wrong direction. If it has been a chronic condition, the patient can get very tired and malnourished.

Emotional distress, anger, and especially resentment often cause liver energy stagnation. Patients with this type of imbalance may also suffer from migraines, depression, insomnia, irritable bowel, and chronic pain in deep tissues.

When the Chinese medicine doctor has gathered all the information and comes up with diagnoses of energy imbalance, an individualized Chinese medicine remedy is formulated.

In most cases, four types of herbs are included in the formula. The first is called emperor. The emperor represents the herbs that treat the main symptoms and their underlying causes.

The second is called minister. The minister helps the emperor to do a better job and also treats accompanying symptoms and their underlying causes.

The third is called assistant. The assistant is the herb that helps both emperor and minister but also harmonizes the formula and eliminates possible toxins and side effects.

See the rest here:

Understanding Chinese Herbal Medicine

Reproductive Medicine Associates of New York Reports Results at ASRM 2013 on Findings Related to Motivations of Women …

NEW YORK, Oct. 14, 2013 /PRNewswire-iReach/ -- Manhattan-based infertility clinic Reproductive Medicine Associates of New York (RMA of New York) has announced the results of a study aimed at identifying the primary motivations behind women who choose to undergo elective oocyte cryopreservation.

What Makes A Woman Freeze: The Impetus Behind Patients' Desires To Undergo Elective Oocyte Cryopreservation by Georgia Witkin, Ph.D., et al., will be presented in an oral session on Monday, October 14th from 4:00 PM to 6:00 PM at the 2013 annual meeting of the American Society for Reproductive Medicine (ASRM) to be held from October 12th through the 17th in Boston, Massachusetts.

The research reveals that women undergo elective oocyte cryopreservation, or "egg freezing" for a variety of social reasons. In her presentation, Dr. Witkin reports that women who had electively chosen to freeze their eggs were commonly concerned that someday they might not medically be able to conceive due to health problems. In other words, they did equate social egg freezing as much a "medical" treatment as an "elective" one.

Other women who participated in the study wanted to preserve their option of future fertility because at the time of consultation, they were neither interested in becoming a single mother by choice nor did they have a partner with whom they wanted to create embryos. The authors also found that egg freezing patients were not yet uncertain whether they wanted to have children in the future.

Georgia Witkin, Ph.D., a clinical psychologist at Reproductive Medicine Associates of New York, counsels women when they consider options for cryopreservation of their eggs. Witkin speaks frequently to the media regarding the topic of egg freezing, and has contributed to articles with The Huffington Post and the Chicago Tribune, citing egg freezing as a matter of control and choice for women who decide to undergo the procedure. In many cases, women who choose egg freezing as an option are uncertain whether they want to have children in the future, however they do not want to miss the opportunity in case they later decide that becoming a parent is important to them. Others may wish to preserve their fertility until they are able to find a partner with which to have a family.

Witkin reported that egg freezing enables women to relax and think more positively about pursuing a career or other life experiences. It can also allow a woman to think less of potential fertility problems, especially in the realm of dating and relationships, and to focus on other aspects of building relationships and forming more positive bonds with potential partners. In all of these cases, oocyte cryopreservation provides a viable option for women who are uncertain of their future reproductive plans.

Georgia Witkin, Ph.D., is a clinical psychologist at Reproductive Medicine Associates of New York, as well as an assistant professor in the Department of Obstetrics and Reproductive Science and in the Department of Psychiatry at Mount Sinai Medical Center. Co-authors of the study include Ann Tran, M.D.; Joseph Lee, B.A.; Lisa Schuman, LCSW; Lawrence Grunfeld, M.D.; and Jaime Knopman, M.D.

About Reproductive Medicine Associates of New York

Reproductive Medicine Associates of New York (RMA of New York) is widely recognized as a national and international leader in state-of-the-art reproductive medicine. Led by an integrated team of doctors and scientists with extensive reproductive endocrinology, fertility and urology experience and training, RMA of New York consistently reports IVF success rates to the Society for Assisted Reproductive Technology (SART) and the Center for Disease Control and Prevention (CDC) and is internationally recognized for achieving high success rates in the treatment of infertility. RMA of New York maximizes access to care by helping patients explore all insurance coverage and financing options available for treatment. RMA of New York is sensitive to the needs of the LGBT community, women choosing single or same-sex motherhood, as well as women interested in elective fertility preservation. Headquartered in midtown Manhattan, RMA of New York has patient care facilities in Garden City, White Plains, Brooklyn and Cornwall, NY. For more information, please visitwww.rmany.com.

Media Contact: Victoria Andretta, Reproductive Medicine Associates of New York, 212-756-5777, vandretta@rmany.com

Read more from the original source:

Reproductive Medicine Associates of New York Reports Results at ASRM 2013 on Findings Related to Motivations of Women ...

Latest emergency medicine research highlights social issues

Public release date: 14-Oct-2013 [ | E-mail | Share ]

Contact: Julie Lloyd 202-370-9292 American College of Emergency Physicians

WASHINGTON Leading researchers in emergency medicine will present more than 400 studies during ACEP13-Scientific Assembly, the annual meeting of the American College of Emergency Physicians in Seattle, Washington. Sponsored by the American College of Emergency Physicians, the Research Forum will be held on Level 3, The Conference Center from 7:00 am to 5:00 pm on Monday, October 14th and Tuesday, October 15th. The Conference Center is part of the Washington State Convention Center.

Researcher physicians will present their latest findings in emergency medicine research, focusing on topics ranging from pediatrics to geriatrics, including toxicology, pain, injury prevention and public health. To search Research Forum by topic, presenter, title and time, visit: http://tinyurl.com/on2o3mm

From noon to 1:00 p.m. on Monday, October 14th, in room 302 of The Conference Center, the Research Forum Awards Luncheon will feature a session on the Patient Centered Outcomes Research Institute's push for comparative effectiveness research with speaker Eric Hess, MD.

At 4:00 p.m. on Monday, October 14th, in room 301 of Level 3 of The Conference Center, Dr. Jeremy Brown, the Director of the Office of Emergency Care Research (OECR) at the National Institutes of Health (NIH), will deliver the keynote address. An ACEP member and emergency physician, Dr. Brown will discuss how this new research center is organized and how it can help emergency care researchers. The OECR coordinates and fosters basic, clinical and translational research and research training for the emergency setting. The NIH is the largest federal agency dedicated to medical research. The formation of the OECR in 2012 was heralded as a significant advance for emergency medicine investigators and emergency patients and the fulfillment of a longstanding goal of ACEP and SAEM.

Each day of the Research Forum will feature a special "state-of-the-art" presentation in room 301 of The Conference Center: Ed Panacek, MD, FACEP, will moderate the presentation on Monday, October 14th at 1:00 p.m.; and Don Yealy, MD, FACEP, will moderate the presentation on Tuesday, October 15th at 8:00 a.m.

The Research Forum will close with a panel session, Cutting Edge: Highlights of Emergency Medicine Research, highlighting some of the most significant emergency medicine research, from 4 p.m. to 5:30 p.m. on Tuesday, October 15th, in room 301. The session will be moderated by Deborah Diercks, MD, FACEP and panelists for this event will include Judd Hollander, MD, FACEP, William Mallon, MD, FACEP and Scott Weingart, MD, FACEP.

Members of the news media can pre-register until September 30th at http://tinyurl.com/mhqm2vw.

Obtain credentials (and the latest daily news about the conference) in the Media Relations Office located at the Washington State Convention Center in room 212. An adjoining News Media Workroom is available for use by the press, and has telephones, internet connections (computers not provided) and workspace to conduct interviews. Members of the media who display ACEP13-Scientific Assembly press credentials have access to all educational sessions, the general session, the Research Forum, and the Exhibit Hall.

More here:

Latest emergency medicine research highlights social issues

Comprehensive Portfolio Prepared by the Alliance for Regenerative Medicine Guides Companies Through Reimbursement …

LA JOLLA, CA--(Marketwired - Oct 14, 2013) - A comprehensive reimbursement guide for regenerative medicine was released today at the third annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum. This guide was developed by the Alliance for Regenerative Medicine (ARM), an international organization representing the regenerative medicine community, and comprises a series of white papers designed to help regenerative medicine companies navigate the reimbursement process.

As with all therapies, regenerative medicine products will need to go through a rigorous evaluation and approval process to receive coverage and payment by public health plans and private insurance. This guide was developed to provide information on the coding, coverage and payment processes, as well as address some of the unique issues regenerative medicine therapies may face along the way. While not specific to any one type of regenerative medicine product, these briefs provide companies with early warnings about pitfalls that can be avoided with proper planning and action.

"We believe it is critical to design and implement a reimbursement strategy early in a product's development process, and this guide will offer valuable, timesaving assistance to companies in the regenerative medicine field," said Antonio Montecalvo, Director of Customer Support Services, Organogenesis Inc., and Chair of ARM's Reimbursement Committee. "The potential for regenerative medicine products to cure diseases is tremendous, and we want to help companies bring these therapies to patients as quickly as possible, which, even after FDA approval, will not happen without adequate health plan coverage."

Specific areas covered in this document include:

"One of ARM's goals is to provide our members with the tools they need to succeed in the marketplace, and this resource will certainly provide a lot of reimbursement assistance. We hear over and over from companies and their investors that this is a topic on which they are seeking guidance," said Michael Werner, Executive Director of ARM. "We are also developing additional tools to help regenerative medicine companies with the development and commercialization of their products."

The Regenerative Medicine Reimbursement Guide is available online at http://alliancerm.org/reimbursement

About The Alliance for Regenerative MedicineThe Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, DC to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. To learn more about ARM or to become a member, visit http://www.alliancerm.org.

Read the rest here:

Comprehensive Portfolio Prepared by the Alliance for Regenerative Medicine Guides Companies Through Reimbursement ...

Science Behind the Medicine and Medical Advances: Unusual Tumors – Neuroendocrine Cancer – Video


Science Behind the Medicine and Medical Advances: Unusual Tumors - Neuroendocrine Cancer
We will explore the discoveries of Vanderbilt #39;s biomedical and engineering labs. Some of these discoveries we may see in our doctors #39; offices very soon. Expe...

By: VanderbiltUniversity

Here is the original post:

Science Behind the Medicine and Medical Advances: Unusual Tumors - Neuroendocrine Cancer - Video

International Space Medicine Summit 2013 — Panel IV: Challenges of Long-duration Flights (Rus) – Video


International Space Medicine Summit 2013 -- Panel IV: Challenges of Long-duration Flights (Rus)
May 18, 2013 Physicians and biomedical scientists gather to discuss space medicine research at this annual conference organized by the Baker Institute and Ba...

By: BakerInstitute

Continue reading here:

International Space Medicine Summit 2013 -- Panel IV: Challenges of Long-duration Flights (Rus) - Video